Figure 1.
Figure 1. NK cells and naive CD4 T cells are weak in mediating tumor rejection. Percentage of tumor-free mice (A) or tumor volume (B) is shown for mice with neither T cells nor NK cells (gc–/–Rag–/–; ▪), or lacking T cells but having NK cells (Rag–/–; •), or mice with naive transgenic C5-specific T cells (A18 TCR transgenic mice; ▴) following subcutaneous inoculation with 5 × 105 C5-transfected LK35 tumor cells. Symbols represent individual animals in groups of 5 mice (A) or mean data for groups of 5 mice (B). (C) IL-2 secretion by naive CD4 A18 TCR transgenic T cells after stimulation with C5-transfected LK35 tumor cells with 1 × 104 DCs (○) or without DCs (•). Mean cpm of [3H] thymidine incorporation by triplicate cultures of IL-2—dependent CTLL cells are shown.

NK cells and naive CD4 T cells are weak in mediating tumor rejection. Percentage of tumor-free mice (A) or tumor volume (B) is shown for mice with neither T cells nor NK cells (gc–/–Rag–/–; ▪), or lacking T cells but having NK cells (Rag/; •), or mice with naive transgenic C5-specific T cells (A18 TCR transgenic mice; ▴) following subcutaneous inoculation with 5 × 105 C5-transfected LK35 tumor cells. Symbols represent individual animals in groups of 5 mice (A) or mean data for groups of 5 mice (B). (C) IL-2 secretion by naive CD4 A18 TCR transgenic T cells after stimulation with C5-transfected LK35 tumor cells with 1 × 104 DCs (○) or without DCs (•). Mean cpm of [3H] thymidine incorporation by triplicate cultures of IL-2—dependent CTLL cells are shown.

Close Modal

or Create an Account

Close Modal
Close Modal